Cutaneous T cell lymphoma

DiseaseDisorder infobox
Name = Cutaneous T cell lymphoma
ICD10 = ICD10|C|84|0|c|81, ICD10|C|84|1|c|81
ICD9 = ICD9|202.1, ICD9|202.2
ICDO = ICDO|9700|3, ICDO|9701|3


Caption =
OMIM =
MedlinePlus =
eMedicineSubj = med
eMedicineTopic = 3486
DiseasesDB = 8595
MeshID = D016410

Cutaneous T-Cell lymphoma (CTCL) is a class of non-Hodgkin's lymphoma, which is a type of cancer of the immune system. Unlike most non-Hodgkin's lymphomas (which are generally B-cell related), CTCL is caused by a mutation of T cells. The malignant T cells in the body are pushed to the surface of the skin in a biological process used to rid the body of offending material, causing various lesions to appear on the skin. These lesions change shape as the disease progresses, typically beginning as what appears to be a rash and eventually forming plaques and tumors before metastasizing to other parts of the body.

Types

Though there are many types of CTCL and presentation can vary from individual to individual, there are two main forms:

* mycosis fungoides (MF)
* Sézary syndrome (SS)

There is some dispute over whether SS is an advanced form of MF or a different type of CTCL entirely - in either case, the prognosis for SS patients is substantially poorer than for those of MF.

Treatment

There is no cure for CTCL, but there are a variety of treatment options available and some CTCL patients are able to live somewhat normal lives with this cancer, although symptoms can be debilitating and painful, even in earlier stages.

Treatments include: Topical Corticosteroids, Bexarotene Gel, Carmustine(Nitrogen Mustard), Mechlorethamine, Phototherapy (Broad & Narrow Band UVB or PUVA), Local & Total Skin Electron Beam Radiation, Conventional Radiation Therapy, Oral Corticosteroids, Bexarotene (Targretin) Capsules, Photopheresis, Interferons, Denileukin Diftitox (Ontak), Alemtuzumab (Campath-1H), Vorinostat (Zolinza), Methotrexate, Pentostatin & other purine analogues (Fludarabine, 2- deoxychloroadenosine), Liposomal doxorubicin (Doxil), Gemcitabine (Gemzar), Cyclophosphamide, oral, Bone marrow/Stem cell, and Allogenic Transplantation.

Epidemiology

Of all cancers involving the same class of blood cell, 2% of cases are cutaneous T cell lymphomas.cite book
author=Turgeon, Mary Louise
title=Clinical hematology: theory and procedures
publisher=Lippincott Williams & Wilkins
location=Hagerstown, MD
year=2005
pages=283
isbn=0-7817-5007-5
quote=Frequency of lymphoid neoplasms. (Source: Modified from WHO Blue Book on Tumour of Hematopoietic and Lymphoid Tissues. 2001, p. 2001.)]

References

ee also

* Anaplastic large cell lymphoma

External links

* [http://www.lymphomainfo.net/nhl/types/ctcl-mf.html Cutaneous T-Cell Lymphomas - The lymphoma Information Network]
* [http://www.clfoundation.org/ The Cutaneous Lymphoma Foundation]
*
* [http://www.lymphoma.org/ Lymphoma Research Foundation]
* [http://www.moffitt.usf.edu/pubs/ccj/v5n1/article1.html Cutaneous T-cell Lymphoma] - H. Lee Moffitt Cancer Center & Research Institute
* [http://uuhsc.utah.edu/healthinfo/adult/skin/cuttcell.htm UUHSC]
* [http://www.clinicaltrials.gov/ct/show/NCT00106431 NCI Clinical Trial using Depsipeptide to treat CTCL]